Edwards Lifesciences
Transcatheter Heart Valve System Model:SAPIEN 3 Ultra RESILIA
Description
The SAPIEN 3 Ultra RESILIA transcatheter heart valve system is indicated for patients with symptomatic heart disease and incorporates Edwards' breakthrough RESILIA tissue technology. RESILIA tissue delivers important advances to the SAPIEN 3 Ultra platform including enhanced calcium blocking properties and dry tissue packaging conditions that facilitate ease of use.
Tags: [Critical Care],[Intensive Care],[Cardiac Care]
New
Hypotension Prediction Software Acumen Hypotension Prediction Index (HPI)
New
Hemodynamic Monitoring Sensor FloTrac Jr
New
Aortic Occlusion Device IntraClude Intra
New
Tissue Oximetry Sensor ForeSight Jr
New
Aortic Valved Conduit KONECT RESILIA
New
Hemodynamic Monitoring System EV1000 Clinical Platform
New
Transcatheter Valve Repair System PASCAL Precision
New
Tissue Oximetry Sensor ForeSight